FDA ALERT
FDA ALERT
11/30/2023

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.
11/30/2023
research summary
research summary
10/26/2023

Leigh Precopio

Leigh Precopio
Despite being approved for use, consensus among the real-world data on the use of IL-23 inhibitors in psoriatic disease has been lacking; therefore, researchers recently examined the drug survival and...
10/26/2023
Research summary
Research summary
10/13/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers aimed to develop a risk prediction model for psoriatic arthritis progression in patients with psoriasis.
10/13/2023
research summary
research summary
09/21/2023

Leigh Precopio

Leigh Precopio
In a recent study, researchers examined the prevalence of comorbidities and risk factors in individuals with newly diagnosed psoriatic arthritis.
09/21/2023
Research Summary
Research Summary
08/16/2023

Anthony Calabro, MA

Anthony Calabro, MA
In a post hoc analysis of two phase 3 trials, researchers set out to determine the impact of sex on tofacitinib in terms of efficacy, safety, and time to discontinuation.
08/16/2023
Research Summary
Research Summary
08/10/2023

Anthony Calabro, MA

Anthony Calabro, MA
In a post hoc analysis of the EXCEED study, researchers found that secukinumab and adalimumab—two biologic disease-modifying antirheumatic medications—showed similar efficacy in the resolution of enthesitis...
08/10/2023
research summary
research summary
06/21/2023

Leigh Precopio

Leigh Precopio
Researchers examined the efficacy and safety of a humanized monoclonal antibody for the treatment of active psoriatic arthritis in some patient populations.
06/21/2023
research summary
research summary
05/16/2023

Leigh Precopio

Leigh Precopio
To better understand the potential benefits of secukinumab use in patients with psoriatic arthritis, researchers examined the proportion of patients being treated with secukinumab that achieved low disease...
05/16/2023
Research Summary
Research Summary
04/28/2023

Jessica Ganga

Jessica Ganga
The researchers evaluated the impact of antirheumatic treatment in women who are pregnant with psoriatic arthritis and how such treatment affects pregnancy outcomes.
04/28/2023
Research Summary
Research Summary
04/13/2023

Jessica Ganga

Jessica Ganga
Researchers conducted a trial to investigate the use of cannabidiol (CBD) to help manage pain in patients with psoriatic arthritis and hand osteoarthritis.
04/13/2023